ossceram nano

Brief Profile
01applicationsmall bone augmentation
02specificfast metabolized β-TCP, slow resorbable HA
03companybredent medical
04illustration
implant
05material60% HA, 40% β-TCP
06approvalsXCE-labeln/aFDA-approval
n/aISOn/aDIN
07last update2017-10-05
not registered / this page is not approved by the provider
Information given here is checked thoroughly by “Implant-Register”. However we can not guarantee for any material or properties. Ask the manufacturer for such questions and give us the information to improve the Register.
Scroll to Top